Picture of NuVasive logo

NUVA — NuVasive News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid Cap

Brief: FDA Says Is Informing Health Care Providers About Potential Biocompatibility Concerns Associated With NuVasive Specialized Orthopedics’ Precice Devices

July 8 (Reuters) - FDA:
    * FDA SAYS IS INFORMING HEALTH CARE PROVIDERS ABOUT
POTENTIAL
BIOCOMPATIBILITY CONCERNS ASSOCIATED WITH NUVASIVE SPECIALIZED
ORTHOPEDICS’ PRECICE DEVICES
    * FDA SAYS NUVASIVE IS PERFORMING ADDITIONAL
BIOCOMPATIBILITY
TESTING ON MATERIALS USED FOR ALL PRECICE DEVICES AGAINST
UPDATED TESTING STANDARDS
    * FDA SAYS NUVASIVE IS ALSO CONDUCTING SERIES OF ASSESSMENTS
OF
POTENTIAL MECHANICAL FAILURES THAT MAY CONTRIBUTE TO
BIOCOMPATIBILITY ISSUES

Further company coverage:  NUVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on NuVasive

See all news